Dr. Berjan Collin, MD

Dr. Collin practices at Midway Specialty Care Center Inc in Port Saint Lucie, Florida.

Dr. Collin's NPI, 1457329468, was assigned on March 8, 2006. Dr. Collin graduated from Vrije Universiteit Brussels in 1983. Dr. Collin holds Florida license ME 74857.

Dr. Collin's primary practice is Midway Specialty Care Center Inc, at 1801 SE Hillmoor Dr, Port Saint Lucie, FL 34952 in Saint Lucie County. The practice phone is (772) 464-9746.

Dr. Collin's primary practice is Midway Specialty Care Center Inc in Port Saint Lucie, Florida. Dr. Collin is also affiliated with HCA Florida St. Lucie Hospital. The medical group on file is Midway Specialty Care Center. Dmand AI also links Dr. Collin to 2 more hospitals, 3 home health agencies, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Collin practices, 8 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Collin's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Collin is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Collin's licenses on file in 2 states: Florida and Minnesota.

Dmand AI lists acute skin infection, cold sores or genital herpes, endocarditis, immune deficiency disease, joint or bone infection, lyme disease, pneumonia and UTI among the conditions Dr. Collin treats.

CMS data shows 157,186 Medicare services from Dr. Collin across 19 procedure codes in 2024, for 790 Medicare patients. Medicare paid $342,294 for them.

CMS counts 790 Medicare patients who saw Dr. Collin in 2024. The largest group is 75 to 84, with 298 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Collin's median patient age at 70, with 47% women.

In 2024, Dr. Collin wrote 1,566 Medicare Part D claims for 387 patients. 93% of them were for generic drugs. CMS names the drug for 1,415 of them, across 28 drugs with 11 or more claims each, at $193,823 in total drug cost. In 2023, CMS named 1,508 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Collin for performance year 2024, reported individually. Dr. Collin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Collin as offering telehealth. CMS counts 14 procedures of removal of tissue by Dr. Collin, more than 65% of the clinicians it reports for that procedure.

CMS Open Payments shows 121 general payments to Dr. Collin from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Gilead Sciences, Inc. paid the most, $614.

Dmand AI lists 1 award for Dr. Collin, most recently CMS Stage 1 2012 in 2012.

Dr. Collin graduated from Vrije Universiteit Brussels in 1983.

Dr. Collin is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.